6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
    10.
    发明授权
    6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations 失效
    6-烯基 - ,6-烷基 - 和6-环氧基 - 埃坡霉素衍生物,其制备方法及其在药物制剂中的用途

    公开(公告)号:US07645891B2

    公开(公告)日:2010-01-12

    申请号:US10965802

    申请日:2004-10-18

    IPC分类号: C07D319/06 C07C49/20

    摘要: This invention describes the new 6-alkenyl- and 6-alkinyl-epothilone derivatives of general formula (I) in which R1a, R1b, R2b, R3a, R3b, R4, R5, R6, R7, A, Y, D, E, G, Y and Z have the meanings that are indicated in the description. The new compounds interact with tubulin by stabilizing microtubuli that are formed. They are able to influence the cell-splitting in a phase-specific manner and thus find use in treating diseases or conditions associated with the need for cell growth, division and/or proliferation. Thus the compounds are suitable for treating malignant tumors, for example, ovarian, stomach, colon, adeno-, breast, lung, head and neck carcinomas, malignant melanoma, acute lymphocytic and myelocytic leukemia. In addition, they are suitable for anti-angiogenesis therapy as well as for treatment of chronic inflammatory diseases (such as psoriasis, arthritis). Methods of use and preparation of the compounds are also described.

    摘要翻译: 本发明描述了通式(I)的新的6-烯基 - 和6-炔基 - 埃坡霉素衍生物,其中R1a,R1b,R2a,R3a,R3b,R4,R5,R6,R7,A,Y,D,E, G,Y和Z具有在说明书中指示的含义。 新化合物通过稳定形成的微管与微管蛋白相互作用。 它们能够以相位特异性方式影响细胞分裂,因此可用于治疗与细胞生长,分裂和/或增殖的需要相关的疾病或病症。 因此,该化合物适用于治疗恶性肿瘤,例如卵巢癌,胃癌,结肠癌,腺癌,乳腺癌,肺癌,头颈癌,恶性黑素瘤,急性淋巴细胞性白血病和骨髓性白血病。 此外,它们适用于抗血管生成治疗以及治疗慢性炎性疾病(如银屑病,关节炎)。 还描述了化合物的使用和制备方法。